ROBBIN DAYRIT: Open Payments
NPI 1861152357 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $91 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Recor Medical Inc | 4 | $110 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| BridgeBio Pharma, Inc. | 2 | $63 |
| HEARTFLOW, INC. | 3 | $59 |
| SCPHARMACEUTICALS INC. | 2 | $52 |
| Esperion Therapeutics, Inc. | 2 | $43 |
| Shockwave Medical, Inc | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| GENZYME CORPORATION | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: Paradise Ultrasound Renal Denervation System, LEQVIO, Attruby, FFRct, FUROSCIX, NEXLETOL, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, WAINUA.
Industry payments across CA — which companies pay providers there.
